| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT05598151 Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors |
Enrollment closed, study ongoing |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07379333 | A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes… | Type 2 Diabetes | Recruiting |
| NCT07660796 | A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential… | Hypertension | Not Yet Recruiting |
| Phase 2 | |||
| NCT07449754 | Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or… | Advanced or Metastatic Melanoma | Recruiting |
| NCT07527650 | Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus | Type 2 Diabetes Mellitus | Recruiting |
| NCT04775706 | Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF… | Short Bowel Syndrome | Recruiting |
| NCT07205900 | Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus | Obese | Active, Not Recruiting |
| NCT04732416 | HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital… | Congenital Hyperinsulinism | Active, Not Recruiting |
| NCT04505436 | Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in… | NASH - Nonalcoholic Steatohepatitis | Active, Not Recruiting |
| Phase 1 | |||
| NCT06724016 | Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or… | Advanced or Metastatic Solid Tumors | Recruiting |
| NCT07219589 | A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants | Obesity | Recruiting |
| NCT06234397 | Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or… | Advanced or Metastatic Solid Tumors | Recruiting |
| NCT07297693 | A Study to Evaluate the Pharmacokinetics and Safety Between HIP2503 and HCP1306 in… | Healthy | Not Yet Recruiting |
| NCT05598151 | Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors | Advanced or Metastatic Solid Tumors | Active, Not Recruiting |